Dr. Bunnell serves as the Morse Family Chief Medical Officer at Dana-Farber Cancer Institute, where he oversees adult and pediatric clinical services and leads strategic clinical operations for the only hospital ranked in the top three nationally by U.S. News & World Report for both adult and pediatric cancer care. Chief medical officer since 2012, Dr. Bunnell has been central to many of Dana-Farber’s most significant operational milestones, including directing Dana-Farber’s clinical response to the Covid-19 pandemic and leading the clinical planning and operational integration for the opening of the Yawkey Center for Cancer Care and the Dana-Farber Cancer Institute–Chestnut Hill (Mass.). These facilities expanded capacity, improved patient experience and extended Dana-Farber’s care model as part of a broader regional access strategy. He is now playing a key leadership role as Dana-Farber plans a new dedicated inpatient cancer hospital, which will be the region’s only independent, free-standing hospital for adult patients with cancer. A breast medical oncologist and associate professor of medicine at Harvard Medical School, Dr. Bunnell is widely recognized for advancing improvements in safety, quality and efficiency of care delivery.
